109068 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression; General methods for enhancing the expression Increasing the copy number of the vector
BIOCONVERSION OF LEVULINIC ACID IN GENETICALLY ENGINEERED HOSTS
#2MODIFIED VIRAL CAPSIDS
#3GENE THERAPY
#4Plasmid Copy Number Regulation and Integration
#5METHOD FOR THE PRODUCTION OF CONSTITUTIVE BACTERIAL PROMOTERS CONFERRING LOW TO MEDIUM EXPRESSION
#6MOLECULES AND METHODS FOR INCREASED TRANSLATION
#7COMPOSITIONS AND METHODS FOR PRODUCTION OF RECOMBINANT ADENO-ASSOCIATED VIRUS
#8REGULATABLE EXPRESSION SYSTEMS
#9Univariant Extrinsic Initiator Control System For Microbes And An In Vitro Assembly Of Large Recombinant DNA Molecules From Multiple Components
#10Amplifiable RNAs for Therapeutic Cell Systems
#11Methods for regulating endogenous production of lactoferrin and sub-peptides thereof
#12RECOMBINANT YEAST STRAIN HAVING STEROL PRODUCTIVITY, PREPARATION METHOD THEREFOR AND USE THEREOF
#13Bioconversion of levulinic acid in genetically engineered hosts
#14Method for improving retroviral transduction and gene editing in hematopoietic stem cells using cyclosporine h (CsH)
#15MODIFIED VIRAL CAPSIDS
#16LONG-ACTING IGF-1 OR IGF-1 VARIANTS AND METHODS OF PRODUCING SAME
#17Gene therapy DNA vector VTvaf17, method of production; strain SCS110-AF, method of production; strain SCS110-AF/VTvaf17 bearing gene therapy DNA vector VTvaf17, method of production
#18RECOMBINANT BACTERIUM CAPABLE OF PRODUCING L-LYSINE, CONSTRUCTION METHOD THEREOF AND PRODUCTION METHOD OF L-LYSINE
#19METHODS FOR REGULATING ENDOGENOUS PRODUCTION OF LACTOFERRIN AND SUB-PEPTIDES THEREOF
#20Univariant extrinsic initiator control system for microbes and an in vitro assembly of large recombinant DNA molecules from multiple components
#21FUNGAL ARTIFICIAL CHROMOSOMES, COMPOSITIONS, METHODS AND USES THEREFOR
#22GENUS KOMAGATAEIBACTER RECOMBINANT MICROORGANISM, METHOD OF PRODUCING CELLULOSE USING THE SAME, AND METHOD OF PRODUCING THE MICROORGANISM
#23BACTERIAL ARTIFICIAL CHROMOSOMES
#24Bioconversion of levulinic acid in genetically engineered hosts
#25ESCHERICHIA COLI T7 EXPRESSION VECTOR, VECTORS FOR THE CO-EXPRESSION AND CO-PURIFICATION OF RECOMBINANT PEPTIDES IN/WITH CARRIER PROTEINS, USE OF EXPRESSION VECTORS FOR OBTAINING COMPLEXES WITH MULTIPLE ANTIGENS AND IMMONOMODULATORS
#26USE OF VITAMINS AND VITAMIN METABOLIC GENES AND PROTEINS FOR RECOMBINANT PROTEIN PRODUCTION IN MAMMALIAN CELLS
#27Fungal artificial chromosomes, compositions, methods and uses therefor
#28Synthetic genes and genetic constructs
#29Bacterial artificial chromosomes
#30Selection vectors and methods of selecting eukaryotic host cells
#31Pan-yeast autonomously replicating sequence
#32Purification process of nascent DNA
#33Plasmid vector, method for detecting gene promoter activity, and assay kit
#34Control of gene expression
#35Synthetic genes and genetic constructs
#36Plasmid vector, method for detecting gene promoter activity, and assay kit
#37CONTROL OF GENE EXPRESSION
#38Process for large scale production of plasmid DNA by fermentation
#39Synthetic genes and genetic constructs
#40Method for selecting a high expression recombinant cell line
#41PROCESS FOR PLASMID DNA FERMENTATION
#42METHOD FOR CONTROLLING PLASMID COPY NUMBER IN E.COLI
#43Compositions and Methods for Controlling Copy Number for a Broad Range of Plasmids and Uses Thereof
#44Portable, Temperature and Chemically Inducible Expression Vector for High Cell Density Expression of Heterologous Genes in Escherichia Coli
#45MUTUALLY SUPPRESSIVE GENE/INHIBITOR COMBINATIONS FOR NON-ANTIBIOTIC SELECTION OF RECOMBINANT STRAINS
#46DNA plasmids with improved copy number
#47Compositions and processes for improved plasmid DNA production
#48Bacterial replication systems and methods
#49CIRCULAR DNA MOLECULE HAVING A CONDITIONAL ORIGIN OF REPLICATION, PROCESS FOR THEIR PREPARATION AND THEIR USE IN GENE THERAPY
#50Mutant PCNA
#51EXPRESSION VECTOR, METHODS FOR THE PRODUCTION OF HETEROLOGOUS GENE PRODUCTS AND FOR THE SELECTION OF RECOMBINANT CELLS PRODUCING HIGH LEVELS OF SUCH OF SUCH PRODUCTS
#52High copy number self-replicating plasmids in pseudomonas
#53Plasmid PXL3179 or NV1FGF
#54Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
#55Hybrid portable origin of replication plasmids
#56Expression vector with enhanced gene expression capacity and method for using the same
#57Method For Genetic Selection Of High-Plasmid Producing E. Coli Clones
#58Process for large scale production of plasmid DNA by fermentation
#59High-Copy-Number, High-Expression Vector Having Methionine Aminopeptidase Gene
#60High copy number plasmids and their derivatives
#61Process for plasmid DNA fermentation
#62Method for Gene Amplification
#63CIRCULAR DNA MOLECULE HAVING A CONDITIONAL ORIGIN OF REPLICATION, PROCESS FOR THEIR PREPARATION AND THEIR USE IN GENE THERAPY
#64Expression Vectors and Methods
#65Expression Vectors and Methods
#66Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
#67Method of altering levels of plasmids
#68Control of gene expression
#69Control of gene expression
#70Method for producing target substance
#71Method of genetic screening using an amplifiable gene
#72System for achieving high expression of genes
#73Expression vectors and methods